RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Omega Funds
O

Omega Funds portfolio

Omega Funds has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is CatalYm's $150M Series B+ round in July 2024, alongside Vesalius Biocapital Partners, Novartis Venture Fund, Jeito Capital and 5 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with Canaan Partners, Brandon Capital and Vesalius Biocapital Partners.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $258M.
Latest deal: CatalYm · Jul 16, 2024.

What Omega Funds invests in

How Omega Funds invests

StageDealsCapital in rounds
Series B+ 2 100%$258M
YearDealsCapital in rounds
2021 1 50%$108M
2024 1 50%$150M

Share is of the 2 rounds on Recent Funding that name Omega Funds. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Omega Funds portfolio companies

CompanyRound with Omega FundsTotal raisedLatest raise
CCatalYm
Health and bio
Series B+ · $150M$259.04MJul 16, 2024
Series B+
SSynthekine
Health and bio
Series B+ · $108M$290MJan 6, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Omega Funds, which is a subset of its real portfolio. API: /api/v1/investors/omega-funds (get a free API key). More: the most active VC firms and new venture capital funds.